192 related articles for article (PubMed ID: 15064933)
1. Assessment of gastrointestinal function and response to megesterol acetate in subjects with gastrointestinal cancers and weight loss.
Deutsch J; Kolhouse JF
Support Care Cancer; 2004 Jul; 12(7):503-10. PubMed ID: 15064933
[TBL] [Abstract][Full Text] [Related]
2. Quality of life and stimulation of weight gain after treatment with megestrol acetate: correlation between cytokine levels and nutritional status, appetite in geriatric patients with wasting syndrome.
Yeh S; Wu SY; Levine DM; Parker TS; Olson JS; Stevens MR; Schuster MW
J Nutr Health Aging; 2000; 4(4):246-51. PubMed ID: 11115810
[TBL] [Abstract][Full Text] [Related]
3. Cytokine activity in cancer-related anorexia/cachexia: role of megestrol acetate and medroxyprogesterone acetate.
Mantovani G; Macciò A; Lai P; Massa E; Ghiani M; Santona MC
Semin Oncol; 1998 Apr; 25(2 Suppl 6):45-52. PubMed ID: 9625383
[TBL] [Abstract][Full Text] [Related]
4. A prospective randomized study of megestrol acetate and ibuprofen in gastrointestinal cancer patients with weight loss.
McMillan DC; Wigmore SJ; Fearon KC; O'Gorman P; Wright CE; McArdle CS
Br J Cancer; 1999 Feb; 79(3-4):495-500. PubMed ID: 10027319
[TBL] [Abstract][Full Text] [Related]
5. A randomized, double-blind, placebo-controlled clinical trial of megestrol acetate as an appetite stimulant in children with weight loss due to cancer and/or cancer therapy.
Cuvelier GD; Baker TJ; Peddie EF; Casey LM; Lambert PJ; Distefano DS; Wardle MG; Mychajlunow BA; Romanick MA; Dix DB; Wilson BA
Pediatr Blood Cancer; 2014 Apr; 61(4):672-9. PubMed ID: 24167059
[TBL] [Abstract][Full Text] [Related]
6. Megestrol acetate and mirtazapine for the treatment of unplanned weight loss in the elderly.
Fox CB; Treadway AK; Blaszczyk AT; Sleeper RB
Pharmacotherapy; 2009 Apr; 29(4):383-97. PubMed ID: 19323618
[TBL] [Abstract][Full Text] [Related]
7. Cytokine involvement in cancer anorexia/cachexia: role of megestrol acetate and medroxyprogesterone acetate on cytokine downregulation and improvement of clinical symptoms.
Mantovani G; Macciò A; Lai P; Massa E; Ghiani M; Santona MC
Crit Rev Oncog; 1998; 9(2):99-106. PubMed ID: 9973244
[TBL] [Abstract][Full Text] [Related]
8. Effect of megestrol acetate and prepulsid on nutritional improvement in patients with head and neck cancers undergoing radiotherapy.
Chen HC; Leung SW; Wang CJ; Sun LM; Fang FM; Hsu JH
Radiother Oncol; 1997 Apr; 43(1):75-9. PubMed ID: 9165140
[TBL] [Abstract][Full Text] [Related]
9. The Efficacy and Safety of Megestrol Acetate in Protein-Energy Wasting due to Chronic Kidney Disease: A Systematic Review.
Wazny LD; Nadurak S; Orsulak C; Giles-Smith L; Tangri N
J Ren Nutr; 2016 May; 26(3):168-76. PubMed ID: 26776251
[TBL] [Abstract][Full Text] [Related]
10. Optimizing end points and outcomes in cancer-associated wasting.
Dahele M; Wall L
J Clin Oncol; 2005 Apr; 23(12):2871-2; author reply 2872-3. PubMed ID: 15838010
[No Abstract] [Full Text] [Related]
11. The effect of cyproheptadine hydrochloride (periactin) and megestrol acetate (megace) on weight in children with cancer/treatment-related cachexia.
Couluris M; Mayer JL; Freyer DR; Sandler E; Xu P; Krischer JP
J Pediatr Hematol Oncol; 2008 Nov; 30(11):791-7. PubMed ID: 18989154
[TBL] [Abstract][Full Text] [Related]
12. Randomized double-blind clinical trial of combined treatment with megestrol acetate plus celecoxib versus megestrol acetate alone in cachexia-anorexia syndrome induced by GI cancers.
Kouchaki B; Janbabai G; Alipour A; Ala S; Borhani S; Salehifar E
Support Care Cancer; 2018 Jul; 26(7):2479-2489. PubMed ID: 29442239
[TBL] [Abstract][Full Text] [Related]
13. [Low doses of megestrol acetate increase weight and improve nutrition status in patients with severe chronic obstructive pulmonary disease and weight loss].
Herrejón A; Palop J; Inchaurraga I; López A; Bañuls C; Hernández A; Blanquer R; Están N; Anguera A
Med Clin (Barc); 2011 Jul; 137(5):193-8. PubMed ID: 21524765
[TBL] [Abstract][Full Text] [Related]
14. Usage of megestrol acetate in the treatment of anorexia-cachexia syndrome in the elderly.
Yeh SS; Lovitt S; Schuster MW
J Nutr Health Aging; 2009 May; 13(5):448-54. PubMed ID: 19390752
[TBL] [Abstract][Full Text] [Related]
15. Using megestrol acetate to ameliorate protein-energy wasting in chronic kidney disease.
Smith CS; Logomarsino JV
J Ren Care; 2016 Mar; 42(1):53-9. PubMed ID: 26537025
[TBL] [Abstract][Full Text] [Related]
16. Loss of lean body and muscle mass correlates with androgen levels in hypogonadal men with acquired immunodeficiency syndrome and wasting.
Grinspoon S; Corcoran C; Lee K; Burrows B; Hubbard J; Katznelson L; Walsh M; Guccione A; Cannan J; Heller H; Basgoz N; Klibanski A
J Clin Endocrinol Metab; 1996 Nov; 81(11):4051-8. PubMed ID: 8923860
[TBL] [Abstract][Full Text] [Related]
17. The effect of megestrol acetate on anorexia, weight loss and cachexia in cancer and AIDS patients (review).
Strang P
Anticancer Res; 1997; 17(1B):657-62. PubMed ID: 9066597
[TBL] [Abstract][Full Text] [Related]
18. Anorexia/cachexia in patients with HIV: lessons for the oncologist.
Von Roenn JH; Knopf K
Oncology (Williston Park); 1996 Jul; 10(7):1049-56; discussion 1062-4, 1067-8. PubMed ID: 8837121
[TBL] [Abstract][Full Text] [Related]
19. [Treatment of uraemic anorexia with megestrol acetate].
Fernández Lucas M; Teruel JL; Burguera V; Sosa H; Rivera M; Rodríguez Palomares JR; Marcén R; Quereda C
Nefrologia; 2010; 30(6):646-52. PubMed ID: 21113214
[TBL] [Abstract][Full Text] [Related]
20. A pilot study of megestrol acetate and ibuprofen in the treatment of cachexia in gastrointestinal cancer patients.
McMillan DC; O'Gorman P; Fearon KC; McArdle CS
Br J Cancer; 1997; 76(6):788-90. PubMed ID: 9310247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
